Skip to main content
Premium Trial:

Request an Annual Quote

Population Genetics Raises $5.7M in Series B Round

NEW YORK (GenomeWeb News) – Population Genetics today announced the closing of a Series B financing round that brought in $5.7 million.

The funds will be used to complete validation of the company's technology, "setting the stage for a future major financing aimed at making that technology broadly available," the UK-based firm said in a statement.

Syngenta Ventures, the VC arm of Syngenta, was a new investor in the round, and joined existing investors Compass Genetics Investors, the Wellcome Trust, Auriga Partners, and Beringea.

Population Genetics also said that it is collaborating with Syngenta to validate Population Genetics' technology in plant breeding studies.

The technology exploits the capabilities of next-generation sequencing to investigate genes that may be associated with diseases in "hundreds, if not thousands of genomes" simultaneously, the company said. The method is "expected to facilitate greatly both the identification and statistical validation of sequence variants associated with phenotypic traits, be they disease pre-dispositions or drug responses in medicine, or … important agronomic plant traits."

The company raised $3.2 million in a Series A round in 2009. Earlier this year, Population Genetics and Quintiles announced they were partnering on an effort to incorporate genomic testing into mainstream drug development.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.